meSDC2 LTE-qMSP showed significant higher frequency of aberrant SDC2 methylation in stool DNA from both CRC (P < 0.01) and adenoma (P < 0.05) patients compared to that in healthy normal subjects (Fig. 3a). This evidence concerns the gene MESD and colorectal carcinoma.